Callouts & quotes from 26,677+ activist slides

"Somehow the subprime lender is the one with the ethics asterisk."

"Recent results have been significantly worse than peer railroads"

"Salesforce should, at a minimum, be in-line with the peer median"

"Not a single change in the # of R&D employees in 3yrs a red flag"

"We call on Mettler to cease its repurchase strategy immediately."

"Perion lost ~18% of its SORT® customers from Q4 2022 to Q1 2023."

"DuPont lacks a consistent reporting methodology for M&A activity"

"つまり、膨らんでいる棚卸資産は、売上原価の過少計上と利益の誇大計上、それらが不自然に高い利益率につながっていると強く連想させる。"

"レーザーテックのキャッシュ変換率は着実に落ちている。とりわけ過去2年間は下降のペースが速まり、直近の2四半期にはさらに下落した。"

"重ねて強調するが、棚卸資産高が膨らみはじめたのは、レーザーテックがACTISの極端紫外線装置を発売した2019年〜2020年だ。"

"このような事実から、レーザーテックの経営陣がイノベーション・パークに関して発信してきた情報がでたらめであることが明らかになった。"

"We believe Viator should grow faster and be much more profitable"

"The Economics of Aurora’s Autonomous Business Model are Hopeless"

"LabCorp has retained the Central Lab and Pre-Clinical businesses"

"Merlyn has no interest in the long-term financial success of TIM"

"Great Gatsby Holiday Party at Pier 48 in San Francisco Cost: $7M"

"All facts continue to confirm that Herbalife is a pyramid scheme"

"The Howard Hughes Corporation’s share price increased 9% in 2014"

"We believe a large margin expansion opportunity exists at Splunk"

"Vertiv is a market leader in data center equipment and services."

"Answer – FFIN is the Belize/Russian version of Alameda Research."

"During the Ullman era the stock fell 14%, despite a ~20% buyback"

"JCP had difficulty attracting high quality brands into its store"

"Meaningful opportunity to grow sales versus 2011 levels and peak"

"Because Medicare covers 80% of the cost as long as they are 65+."

"Our concerns with Bunge's financial reporting are not unfounded."

"Do you want to take a leap of faith on my financial projections?"

"Under Mr. Ferrari’s Oversight Venator’s Share Price Declined 90%"

"2023 Return: PSH NAV Net of Fees vs. Indices Total Return in USD"

"Bloomberg publishes article on Pershing Square / ADP at 12:43 PM"

"Wall Street analysts were shocked by Pfizer's recall of OXBRYTA."

"<2x multiple would have been great compared to market multiples!"

"Management expected doses sold to increase every year after 2023"

"Created a strong path forward that reminds us of our early roots"

"Heska has gained little share against market leaders since 2013."

"We Believe Heska's Subscription Business Disclosure is Troubling"

"Why do analysts ignore the human cost of delivering its service?"

"We want to be a company that is not compared to P&G or Unilever."

"Kao's Curél brand displayed with poor shelf space and no signage"

"Presence in all top 31 markets, with a #1 position in 18 markets"

"LabCorp has retained the Central Lab and Pre-Clinical businesses"

"When we engaged with Marathon, our base case implied +60% upside"

"ウシオのフィールド・サービス・エンジニアはUrashima光源が「ウシオ製の光源と少なくとも同じほどのダウンタイムです」と語る。"

"Incremental Compensation Cost of $25M is a Reasonable Assumption"

"One-Time Earnings Addbacks Have Increased EPS by 8.1% on Average"

"Street estimates show margin gap persisting at NSC through 2026."

"As EVP for PSR, Mr. Fahmy created value for KCS shareholders by:"

"BMI alone reduces Inspire’s addressable market by more than 30%."

"VGo offers a solution for 1/10th of the cost of IRBT’s solution."

"Insurers "playing chicken" and not approving Vykat prescriptions"

"All facts continue to confirm that Herbalife is a pyramid scheme"

"<2x multiple would have been great compared to market multiples!"

"Beginning in January 2015 we were free to acquire Valeant shares"

"All facts continue to confirm that Herbalife is a pyramid scheme"

"The common debt structure in an LBO is 4x Term Loan and 2x Bond."

"We examined this claim and found it to be egregiously deceptive."

"All facts continue to confirm that Herbalife is a pyramid scheme"

"Cash flow is so microscopic it is not even visible on the Y-axis"

"Peroxides is a high margin business and generates a lot of cash."

"Spruce Point first to warn of lower cost, competitive disruption"